Live price temporarily unavailable.
Bright Minds Biosciences Inc (DRUG) is a Health Care company in the Russell 2000. Latest news and coverage below.
EU panel backs AstraZeneca breast cancer drug camizestrant
EU panel backs AstraZeneca breast cancer drug camizestrant
Goldman Sachs initiates Hemab Therapeutics stock with buy rating on rare disease drug potential
Goldman Sachs initiates Hemab Therapeutics stock with buy rating on rare disease drug potential
Guggenheim initiates Avalyn Pharma stock with buy rating on fibrosis drugs
Guggenheim initiates Avalyn Pharma stock with buy rating on fibrosis drugs
Pfizer’s SWOT analysis: stock navigates patent cliff with new drugs
Pfizer’s SWOT analysis: stock navigates patent cliff with new drugs
AI may speed up search for drugs to treat brain conditions
Researchers hope the work will help identify affordable, effective drugs to treat conditions like MND.
New High Street crime unit to target gangs fronting shops after BBC investigation
It follows BBC News exposing drug gangs, money laundering, immigration crime, and ghost directors linked to shop fronts.